# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases The re...
Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover.
- Bloomberg
Partnership will expand Evotec's molecular patient database in the area of metabolic diseases and in particular obesity ...